Yajun Cheng (Former)
1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Understanding the Molecular Activity of Alkaline Sphingomyelinase (NPP7) by Computer Modeling
(
- Contribution to journal › Article
- 2009
-
Mark
Ezetimibe Inhibits Expression of Acid Sphingomyelinase in Liver and Intestine.
(
- Contribution to journal › Article
-
Mark
Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine
2009) 50th International Conference on Bioscience of Lipids In Chemistry and Physics of Lipids 160. p.33-33(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats
(
- Contribution to journal › Article
- 2007
-
Mark
Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites.
(
- Contribution to journal › Article
-
Mark
Curcumin decreases acid sphingomyelinase activity in colon cancer caco-2 cells
(
- Contribution to journal › Article
-
Mark
Effects of bile diversion in rats on intestinal sphingomyelinases and ceramidase.
(
- Contribution to journal › Article
-
Mark
Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis.
(
- Contribution to journal › Article
- 2006
-
Mark
Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells.
(
- Contribution to journal › Article
-
Mark
Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity
(
- Contribution to journal › Article